Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03870399
Title Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression (HORMONET)
Acronym HORMONET
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AC Camargo Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BRA


No variant requirements are available.